Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Boston Scientific: Overleveraged To The Coronary Stent Market
Boston Scientific: Overleveraged To The Coronary Stent Market
Boston Scientific: Overleveraged To The Coronary Stent Market
Submitted by
moderatorj
on February 28, 2012 - 10:12pm
Source:
Seeking Alpha
News Tags:
Boston Scientific
stent
Headline:
Boston Scientific: Overleveraged To The Coronary Stent Market
Do Not Allow Advertisers to Use My Personal information
